Incidence of hepatocellular carcinoma reduced by phlebotomy treatment in patients with chronic hepatitis C

被引：0
|
作者：
Sasaki, Shoichi [1 ]
Nirei, Kazushige [1 ]
Matsuoka, Shuniti [1 ]
Nakamura, Hitomi [1 ]
Moriyama, Mitsuhiko [1 ]
机构：
[1] Nihon Univ, Sch Med, Dept Gastroenterol & Hepatol, Tokyo, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1281
引用
收藏
页码：383 / 384
页数：2
相关论文
共 50 条
  • [41] Does interferon treatment reduce hepatocellular carcinoma incidence in HBeAg positive chronic hepatitis B patients?
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fukushima, Taito
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    [J]. HEPATOLOGY, 2014, 60 : 1120A - 1120A
  • [42] Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
    Takao Watanabe
    Yoshio Tokumoto
    Kouji Joko
    Kojiro Michitaka
    Toshie Mashiba
    Atsushi Hiraoka
    Hironori Ochi
    Yohei Koizumi
    Fujimasa Tada
    Masashi Hirooka
    Osamu Yoshida
    Yusuke Imai
    Masanori Abe
    Yoichi Hiasa
    [J]. Hepatology International, 2016, 10 : 320 - 327
  • [43] Incidence of hepatocellular carcinoma in chronic infection with hepatitis B
    Ntagirabiri, Renovat
    Munezero, Belyse
    Kaze, Hippolyte
    Ndirahisha, Eugene
    Manirakiza, Sebastien
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2015, 20
  • [44] Phlebotomy followed by interferon-alpha treatment in patients with chronic hepatitis C.
    Fracassetti, O
    Tambini, R
    Bellavita, P
    Vicari, O
    Sonzogni, A
    Lorenzi, N
    Delvecchio, G
    Gavazzeni, G
    [J]. HEPATOLOGY, 1996, 24 (04) : 1543 - 1543
  • [45] Hepatocellular carcinoma incidence is reduced in cirrhotic chronic hepatitis B patients with HBsAg seroclearance comparing to those with viral suppression
    Jeng, Rachel Wen-Juei
    Chen, Chien-Hung
    Yang, Hwai-I
    Chen, Yi-Cheng
    Liu, Yen-Chun
    Wu, Chia-Ying
    Chien, Rong-Nan
    Liaw, Yun-Fan
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S102 - S102
  • [46] Challenges in Treatment of Hepatitis C Among Patients With Hepatocellular Carcinoma
    Saberi, Behnam
    Dadabhai, Alia S.
    Durand, Christine M.
    Philosophe, Benjamin
    Cameron, Andrew M.
    Sulkowski, Mark S.
    Gurakar, Ahmet
    [J]. HEPATOLOGY, 2017, 66 (02) : 661 - 663
  • [47] Antiviral therapy in patients with chronic hepatitis C related hepatocellular carcinoma responding to palliative treatment
    Lee, J. I.
    Lee, K. S.
    Kim, J. K.
    Yoo, J. H.
    Chang, H. Y.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S531 - S531
  • [48] Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment
    Sargsyan, Sona
    Magdesieva, Hripsime
    Navoyan, Tsoghik
    Mkhitaryan, Aregnaz
    Atoyan, Lusine
    Sargsyan, Violeta
    Harutyunyan, Hayk
    Azatyan, Vahe
    Minasyan, Armine
    Gyulazyan, Naira
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (05): : 794 - 801
  • [49] Significant factors for incidence of hepatocellular carcinoma after sustained virological response to antiviral treatment for chronic hepatitis C
    Furusyo, N.
    Murata, M.
    Ogawa, E.
    Nomura, H.
    Hayashi, J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S129 - S130
  • [50] Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality
    Liu, Chun-Jen
    Chu, Yu-Tseng
    Shau, Wen-Yi
    Kuo, Raymond N.
    Chen, Pei-Jer
    Lai, Mei-Shu
    [J]. GUT, 2014, 63 (03) : 506 - 514
12345